Haemophilia And Blood Products
EDM number 417 in 2002-03, proposed by Michael Connarty on 18/12/2002.
That this House notes the recent report highlighting that the United Kingdom has the lowest provision of recombinant product for the use of people with haemophilia in the developed world; notes the recent medical concerns suggesting vCJD might be carried in infected blood products, and calls on the Government to make this synthetic alternative to blood products available to all people with haemophilia without further delay and thereby remove from patients with haemophilia the fear that the blood products that they rely on daily for treatment may pass on this terrible disease.
This motion has been signed by a total of 119 MPs.
Download raw data as csv or xml.